Aktiesnakken — Juni 2011
-
så de er ikke et issoleret genmab problem
-
Genmab er så bare blevet ramt af en trist nedlukning af deres næst vigtigste stof. Og det skal naturligvis
-
koste ekstra på kursen
-
Nu går C20 gudhjælpemig i minus.
-
Godt man har lidt svensk til at trække op.
-
Jeg har godt nok ondt af dem der har siddet med FLS fra 550 og ned.
-
Jo, men Pandora og Vestas synes jeg i mit stille sind m
an selv har været ude om.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind